Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weida Wang

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Leukemia|August 1, 2025
The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myelomaYun Wang, Shuzhao Chen, Zhijian Liang, et al.
EMBO Molecular Medicine|December 13, 2021
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancerQian Zhou, Jinxia Liang, Tong Yang, et al.
Scientific Data|December 4, 2025
S2R-Bench: A Sim-to-Real Evaluation Benchmark for Autonomous DrivingLi Wang, Guangqi Yang, Lei Yang, et al.
Scientific Data|March 14, 2025
Dual Radar: A Multi-modal Dataset with Dual 4D Radar for Autononous DrivingXinyu Zhang, Li Wang, Jian Chen, et al.
NPJ Primary Care Respiratory Medicine|June 4, 2021
A predictive score for progression of COVID-19 in hospitalized persons: a cohort studyJingbo Xu, Weida Wang, Honghui Ye, et al.
Annals of Hematology|September 6, 2020
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center studyJing Li, Li Bao, Zhongjun Xia, et al.
Journal of Hematology & Oncology|January 11, 2018
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemiaJinghua Wang, Siyu Chen, Wei Xiao, et al.
Annals of Hematology|February 4, 2026
Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match studyYun Wang, Xiaoqin Chen, Qi Liang, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Leukemia|August 1, 2025
The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myelomaYun Wang, Shuzhao Chen, Zhijian Liang, et al.
EMBO Molecular Medicine|December 13, 2021
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancerQian Zhou, Jinxia Liang, Tong Yang, et al.
Scientific Data|December 4, 2025
S2R-Bench: A Sim-to-Real Evaluation Benchmark for Autonomous DrivingLi Wang, Guangqi Yang, Lei Yang, et al.
Scientific Data|March 14, 2025
Dual Radar: A Multi-modal Dataset with Dual 4D Radar for Autononous DrivingXinyu Zhang, Li Wang, Jian Chen, et al.
NPJ Primary Care Respiratory Medicine|June 4, 2021
A predictive score for progression of COVID-19 in hospitalized persons: a cohort studyJingbo Xu, Weida Wang, Honghui Ye, et al.
Annals of Hematology|September 6, 2020
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center studyJing Li, Li Bao, Zhongjun Xia, et al.
Journal of Hematology & Oncology|January 11, 2018
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemiaJinghua Wang, Siyu Chen, Wei Xiao, et al.
Annals of Hematology|February 4, 2026
Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match studyYun Wang, Xiaoqin Chen, Qi Liang, et al.
Pageof 8